Concepedia
Statistics
Publications
5
Citations
136
H-Index
Active since
2022
Affiliations
Retina Consultants of Texas(Current)
Novartis (United States)
University of California, Los Angeles
Rutgers, The State University of New Jersey
Doheny Eye Institute
Eser Adiguzel is an author at Retina Consultants of Texas specializing in macular disorders, ophthalmology, and ocular disease.
Publications per year
2022–2024
MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid
Arshad M. Khanani, David M. Brown, Glenn J. Jaffe et al. · Ophthalmology · 2022 · 71 citations
Medicine, Ophthalmology, Pharmacotherapy +13
One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry
Mathew W. MacCumber, Charles C. Wykoff, Hélène Karcher et al. · Ophthalmology · 2023 · 19 citations
Medicine, Ophthalmology, Surgery +12
Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
Marco A. Zarbin, Mathew W. MacCumber, Hélène Karcher et al. · Ophthalmology and Therapy · 2024 · 19 citations · Full text
Medicine, Ophthalmology, Pharmacotherapy +16
MERLIN: Two-Year Results of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid
David M. Brown, Glenn J. Jaffe, Charles C. Wykoff et al. · Ophthalmology · 2024 · 15 citations · Full text
Medicine, Ophthalmology, Pharmacotherapy +17
Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab
Mathew W. MacCumber, Charles C. Wykoff, Hélène Karcher et al. · Ophthalmology · 2023 · 12 citations
Medicine, Ophthalmology, Pharmacotherapy +12
1–5 of 5